Ozempic is a brand-name glucagon-like peptide-1 (GLP-1) medication approved by the U.S. Food and Drug Administration (FDA) to manage blood sugar in individuals with type 2 diabetes. In May 2026, ...
Some find freedom from food noise. Others face new risks.
A wave of prescription weight-loss medications has swept across Australia, reshaping how doctors treat obesity and forcing regulators into a race to keep up with demand.
GLP‑1 receptor agonists, including semaglutide and tirzepatide (marketed as Ozempic, Wegovy and Mounjaro), have transformed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results